Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

108 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Association of Palliative Care Consultation in Patients With Heart Failure With Preserved Ejection Fraction With Symptom Burden and Health Care Use.
Warraich HJ, Godfrey S, Makwana B, Abraham S, Aglan A, Saji AM, Khadke S, Patel R, Kumar A, Patel V, Parikh A, Banker A, Venesy D, Shah S, Winzelberg GS, Nohria A, Dani SS, Ganatra S. Warraich HJ, et al. Among authors: banker a. JACC Adv. 2024 Dec 4;4(1):101431. doi: 10.1016/j.jacadv.2024.101431. eCollection 2025 Jan. JACC Adv. 2024. PMID: 39697769 Free PMC article.
Bilateral Anti-VEGF on Same-Day-Investigation on Safety in Retinopathy of Prematurity: A Multicenter Retrospective Study.
Gangwe AB, Agrawal A, Jalali S, Banker A, Padhi T, Shah P, Rajan RP, Kulkarni S, Shah S, Singhal R, Das P, Kapoor A, Vinekar A, Bavaskar S, Vedantham V, Sanghi G, Bhattacharya S, Banker A, Gaikwad A, Shrivastava S, Nayak S, Panchal B, Agrawal D, Azad RV. Gangwe AB, et al. Among authors: banker a. Ophthalmol Retina. 2024 Nov 12:S2468-6530(24)00534-7. doi: 10.1016/j.oret.2024.11.004. Online ahead of print. Ophthalmol Retina. 2024. PMID: 39536805
Validation of the Online Collaborative Ocular Tuberculosis Study Calculator for Tubercular Uveitis.
Zhang L, Rojas-Carabali W, Choo SS, Thng ZX, Lim YH, Lee B, Jun SW, Patnaik G, Biswas J, Agarwal A, Testi I, Mahajan S, Kempen JH, Smith JR, McCluskey P, Kon OM, Nguyen QD, Pavesio C, Gupta V, Agrawal R; Collaborative Ocular Tuberculosis Study (COTS) Group. Zhang L, et al. JAMA Ophthalmol. 2024 Dec 1;142(12):1140-1148. doi: 10.1001/jamaophthalmol.2024.4567. JAMA Ophthalmol. 2024. PMID: 39480402
Use of immunomodulatory treatment for non-infectious uveitis: an International Ocular Inflammation Society report of real-world practice.
Branford JA, Bodaghi B, Ferreira LB, McCluskey PJ, Thorne JE, Matthews JM; International Study Group for Systemic Immunomodulatory Drug Treatment of Non‐Infectious Uveitis; Smith JR. Branford JA, et al. Br J Ophthalmol. 2024 Nov 1:bjo-2024-326239. doi: 10.1136/bjo-2024-326239. Online ahead of print. Br J Ophthalmol. 2024. PMID: 39472042
GLP-1 Receptor Agonists Among Patients With Overweight or Obesity, Diabetes, and HFpEF on SGLT2 Inhibitors.
Patel R, Wadid M, Makwana B, Kumar A, Khadke S, Bhatti A, Banker A, Husami Z, Labib S, Venesy D, Fonarow G, Kosiborod M, Al-Kindi S, Bhatt DL, Dani S, Nohria A, Butler J, Ganatra S. Patel R, et al. Among authors: banker a. JACC Heart Fail. 2024 Nov;12(11):1814-1826. doi: 10.1016/j.jchf.2024.07.006. Epub 2024 Aug 28. JACC Heart Fail. 2024. PMID: 39207323
Anti-VEGF Biosimilars for Retinal Diseases Survey 2023- India (Bio-INDAS) by the International Retina Biosimilar Study Group (Inter-BIOS Group) in collaboration with the Vitreo-Retinal Society of India (VRSI).
Sharma A, Kaiser PK, Tadayoni R, Holz FG, Nicholson L, Vazquez-Alfageme C, Sivaprasad S, Wakabayashi T, Woo SJ, Sarraf D, Kumar N, Parachuri N, Regillo CD, Rezaei KA, Khanani AM, Bandello F, Shanamugam M, Verma L, Dogra MR, Ns M, Agarwal M, Loewenstein A, Kuppermann BD; International Retina Biosimilar Study Group (Inter BIOS Group). Sharma A, et al. Eye (Lond). 2024 Dec;38(17):3392-3395. doi: 10.1038/s41433-024-03284-x. Epub 2024 Aug 26. Eye (Lond). 2024. PMID: 39187656 No abstract available.
Biosimilar ranibizumab (BS1) - early experience from Japan (BRIJ study).
Ueda-Consolvo T, Ishida M, Nakamura T, Yanagisawa S, Tsuboi K, Wakabayashi T, Hayashi A, Sharma A; International Retina Biosimilar Study Group (Inter BIOS Group). Ueda-Consolvo T, et al. Eye (Lond). 2024 Nov;38(16):3193-3196. doi: 10.1038/s41433-024-03220-z. Epub 2024 Jul 23. Eye (Lond). 2024. PMID: 39043816 No abstract available.
108 results